Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2021-004374
Abstract: Introduction It has been recognized that increasing body mass index (BMI) is associated with improved outcome from immune checkpoint inhibitors (ICIs) in patients with various malignancies including non-small cell lung cancer (NSCLC). However, it is… read more here.
Keywords: body mass; chemoimmunotherapy combinations; bmi; mass index ... See more keywords